Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Sickle cell disease and the heart: Awareness increases in cardiology community
• L. Samuel Wann, MD, MACC, FAHA, FESC, reflects on a career of CV imaging and beyond
• 2 decades of structural heart disease
• Antibiotics, QT prolongation, TdP and sudden death: Fact or fiction Raymond L. Woosley, MD, PhD
• Biotronik announces FDA approval of ICD systems for patients with HF
• DCB approved to treat US patients with PAD
• Pericardial aortic surgical valve receives FDA approval, CE mark
• ACC/AHA/HRS guideline provides recommendations for diagnosis, prognosis for syncope
• ECG risk score may predict sudden cardiac arrest in certain patients
• Healthful plant-based diet may decrease risk for CHD
• High sodium intake harms cardiac structure, function
• LICORN: Levosimendan shows no benefit for cardiac output after CABG
• Mortality decreasing for ischemic heart disease, rising for HF in US
• Mortality higher for women while awaiting urgent heart transplant
• Patients with paroxysmal AF may be undertreated with anticoagulants
• PCI with complete revascularization yields similar survival to CABG
• Positive airway pressure fails to improve CV outcomes in sleep apnea
• Readmission decline may be linked to lower mortality in acute MI, HF, pneumonia
• ROOBY-FS: Event-free survival rates lower with off-pump CABG
• Smoking cessation medication may be underutilized in older patients after MI
• Statin discontinuation post-stroke increases risk for recurrence
• Targeting ANGPTL3 may reduce atherogenic lipoproteins
• Technology may reverse cell aging process, reduce early CVD risk
• Use of nitroprusside, isoproterenol declined after price spike
• Weight gain may affect heart structure, increase risk for HF
• Angioplasty, bypass surgery options for patients with diabetes, CAD
• Different approach to CVD risk assessment should be taken in patients with diabetes
• Future holds promise to address unmet needs in lipid disorders causing CV risk
• Glycemic control key factor in reducing CV risk
• Lowering LDL, regardless of method, can reduce CV risk in patients with diabetes
• Stroke rates higher in asymptomatic vs. symptomatic AF
• Trial Scorecard: ASSERT-II
• Trial Scorecard: BIONICS
• Trial Scorecard: FL-PR CReSD
• Trial Scorecard: FORWARD
• Trial Scorecard: LICORN
• Trial Scorecard: QUIDAM
• Trial Scorecard: RESPONSE-2
• Trial Scorecard: ROOBY-FS
• Pregnancy, sex differences important areas of women’s CV health Ki Park, MD, MS, FSCAI